4th Quarter - Report
FARRAGUT PARTNERS LLP for SPECTRUM PHARMACEUTICALS, INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2022 | $60,000 | Replaced |
| 4th Quarter - Amendment | Oct 28, 2022 | $60,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to exon 20 cancer mutation. Issues related to FDA remote foreign site inspections
| Lobbyist | Covered position, as disclosed |
|---|---|
| JODY SHINTARO GALE | — |
| WILLIAM KRIEGER | — |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (RTexas) |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte LA Rep Whitfield and Intern Devin Nunes |
| KRISTEN O'NEILL | Health Policy Advisory, LA, Staff Assistant Gene Greene (DTX) Staff Assistant GK Butterfield (D-NC) |
| J DANIEL WALSH | LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux |
| EDWARD WHITFIELD | U.S. Representative (21 yrs.) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.